Publications by authors named "Josef Krejci"

Intradermal (i.d.) application of vaccine is promising way how to induce specific immune response against particular pathogens.

View Article and Find Full Text PDF

Clostridium difficile is a major nosocomial pathogen in humans with an increasing incidence in the community. The "one-health" approach of research is needed to investigate possible reservoirs of C. difficile and route of its transmission.

View Article and Find Full Text PDF

The effects of intradermal application of antigen with or without different adjuvants and activation of immune response are presented in this study. Six groups of six piglets each were immunized with keyhole limpet haemocyanin (KLH) antigen in combination with aluminium hydroxide or oil-based adjuvants (complete and incomplete Freund's adjuvants, Montanide ISA 206 and Emulsigen). IgG1 and IgG2 levels in sera were measured by KLH-specific ELISA.

View Article and Find Full Text PDF

The authors summarize information on the basic aspects of MRSA infections. Special attention is concentrated on the epidemiology of these infections, risk factors facilitating their transmission and spread in hospitals. Furthermore, this paper attempts to evaluate methods used to reduce their occurrence and pays attention to the procedures aimed at identifying the sources of infection, including carriers and patients.

View Article and Find Full Text PDF

The ability of different adjuvants to enhance immune responses to intradermal (ID) immunisation with a model antigen was studied in pigs. Immune responses were evaluated with respect to the intensity of systemic and mucosal antibody formation, their isotype characterisation and rate of cell-mediated immunity. These findings were compared with the intensity of adverse local reactions.

View Article and Find Full Text PDF

The aim of our study was to extend knowledge about possibilities of replacing challenge tests by in vitro methods in cattle on the model of trichophytosis. We correlated results of three in vitro tests for the detection of immune response, i.e.

View Article and Find Full Text PDF

The need for safe and structurally defined immunomodulators and adjuvants is increasing in connection with the recently observed marked increase in the prevalence of pathological conditions characterized by immunodeficiency. Important groups of such compounds are muramyl glycopeptides, analogs of muramyl dipeptide (MDP), glucosaminyl-muramyl dipeptide (GMDP), and desmuramylpeptides. We have designed and synthesized new types of analogs with changes in both the sugar and the peptide parts of the molecule that show a high immunostimulating and adjuvant activity and suppressed adverse side effects.

View Article and Find Full Text PDF